Cocaine	Cocaine	NN	B-NP	O	
regulates	regulate	VBZ	B-VP	O	
the	the	DT	B-NP	O	
transcription	transcription	NN	I-NP	B-protein	
factor	factor	NN	I-NP	I-protein	
CREB	CREB	NN	I-NP	B-protein	Mention 248	
(	(	(	O	O	
adenosine	adenosine	NN	B-NP	O	Mention 249	
3	3	CD	I-NP	O	
'	'	SYM	B-NP	O	
,	,	,	O	O	
5'-monophosphate	5'-monophosphate	NN	B-NP	B-DNA	
response	response	NN	I-NP	I-DNA	
element	element	NN	I-NP	I-DNA	
binding	binding	NN	I-NP	O	
protein	protein	NN	I-NP	O	
)	)	)	O	O	
in	in	IN	B-PP	O	
rat	rat	NN	B-NP	O	Mention 250	
nucleus	nucleus	NN	I-NP	O	
accumbens	accumben	VBZ	B-VP	O	
,	,	,	O	O	
a	a	DT	B-NP	O	Mention 251	
brain	brain	NN	I-NP	B-DNA	
region	region	NN	I-NP	I-DNA	
that	that	WDT	B-NP	O	
is	be	VBZ	B-VP	O	
important	important	JJ	B-ADJP	O	
for	for	IN	B-PP	O	
addiction	addiction	NN	B-NP	O	
.	.	.	O	O	
Overexpression	Overexpression	NN	B-NP	O	
of	of	IN	B-PP	O	
CREB	CREB	NN	B-NP	B-protein	
in	in	IN	B-PP	O	
this	this	DT	B-NP	O	Mention 252	
region	region	NN	I-NP	O	
decreases	decrease	VBZ	B-VP	O	
the	the	DT	B-NP	O	
rewarding	rewarding	JJ	I-NP	O	
effects	effect	NNS	I-NP	O	
of	of	IN	B-PP	O	
cocaine	cocaine	NN	B-NP	O	
and	and	CC	O	O	
makes	make	VBZ	B-VP	O	
low	low	JJ	B-NP	O	
doses	dose	NNS	I-NP	O	
of	of	IN	B-PP	O	
the	the	DT	B-NP	O	
drug	drug	NN	I-NP	O	
aversive	aversive	JJ	B-ADJP	O	
.	.	.	O	O	
Conversely	Conversely	RB	B-ADVP	O	
,	,	,	O	O	
overexpression	overexpression	NN	B-NP	O	
of	of	IN	B-PP	O	
a	a	DT	B-NP	O	
dominant-negative	dominant-negative	JJ	I-NP	B-protein	
mutant	mutant	JJ	I-NP	I-protein	
CREB	CREB	NN	I-NP	I-protein	
increases	increase	VBZ	B-VP	O	
the	the	DT	B-NP	O	
rewarding	rewarding	JJ	I-NP	O	
effects	effect	NNS	I-NP	O	
of	of	IN	B-PP	O	
cocaine	cocaine	NN	B-NP	O	
.	.	.	O	O	
Altered	Altered	JJ	B-NP	O	
transcription	transcription	NN	I-NP	O	
of	of	IN	B-PP	O	
dynorphin	dynorphin	NN	B-NP	O	
likely	likely	RB	B-ADVP	O	
contributes	contribute	VBZ	B-VP	O	
to	to	TO	B-PP	O	
these	these	DT	B-NP	O	
effects	effect	NNS	I-NP	O	
:	:	:	O	O	
Its	Its	PRP$	B-NP	O	
expression	expression	NN	I-NP	O	
is	be	VBZ	B-VP	O	
increased	increase	VBN	I-VP	O	
by	by	IN	B-PP	O	
overexpression	overexpression	NN	B-NP	O	
of	of	IN	B-PP	O	
CREB	CREB	NN	B-NP	B-protein	
and	and	CC	O	O	
decreased	decrease	VBN	B-VP	O	
by	by	IN	B-PP	O	
overexpression	overexpression	NN	B-NP	O	
of	of	IN	B-PP	O	
mutant	mutant	JJ	B-NP	B-protein	
CREB	CREB	NN	I-NP	I-protein	
.	.	.	O	O	
Moreover	Moreover	RB	B-ADVP	O	
,	,	,	O	O	
blockade	blockade	NN	B-NP	O	Mention 253	
of	of	IN	B-PP	O	
kappa	kappa	NN	B-NP	B-protein	
opioid	opioid	JJ	I-NP	I-protein	
receptors	receptor	NNS	I-NP	I-protein	
(	(	(	O	O	
on	on	IN	B-PP	O	
which	which	WDT	B-NP	O	Mention 254	
dynorphin	dynorphin	NN	B-NP	O	
acts	act	VBZ	B-VP	O	
)	)	)	O	O	
antagonizes	antagonize	VBZ	B-VP	O	
the	the	DT	B-NP	O	
negative	negative	JJ	I-NP	O	
effect	effect	NN	I-NP	O	
of	of	IN	B-PP	O	
CREB	CREB	NN	B-NP	B-protein	
on	on	IN	B-PP	O	
cocaine	cocaine	NN	B-NP	O	
reward	reward	NN	I-NP	O	
.	.	.	O	O	
These	These	DT	B-NP	O	
results	result	NNS	I-NP	O	
identify	identify	VBP	B-VP	O	
an	an	DT	B-NP	O	
intracellular	intracellular	JJ	I-NP	O	
cascade-culminating	cascade-culminating	NN	I-NP	O	
in	in	IN	B-PP	O	
gene	gene	NN	B-NP	O	
expression-through	expression-through	NN	I-NP	O	
which	which	WDT	B-NP	O	
exposure	exposure	NN	I-NP	O	
to	to	TO	B-PP	O	
cocaine	cocaine	NN	B-NP	O	
modifies	modify	VBZ	B-VP	O	
subsequent	subsequent	JJ	B-NP	O	
responsiveness	responsiveness	NN	I-NP	O	
to	to	TO	B-PP	O	
the	the	DT	B-NP	O	
drug	drug	NN	I-NP	O	
.	.	.	O	O	
